ArticleDisease markers2022

miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction.

Yingqian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.